Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
  1. 4 Open-market buy Director bought 2,370 shares at an average $10.42 ($24,689)
  2. 4 Open-market buy Exec. VP and COO bought 960 shares at $10.31 ($9,898)
  3. 4 Open-market buy Chief Executive Officer bought 965 shares at $10.34 ($9,980)
  4. 4 Open-market buy Director bought 3,000 shares at $10.95 ($32,850)
  5. 4 Open-market buy Director bought 3,000 shares at an average $10.55 ($31,660)
  6. 4 Open-market buy Director bought 1,500 shares at $9.27 ($13,898)
  7. 4 Shares withheld for taxes Exec. VP and COO gave up 31 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Executive Officer gave up 113 shares (to pay taxes)
  9. 4 Open-market sale Exec. VP and COO sold 35,321 shares at $18.60 ($657,020)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Director bought 2,550 shares at an average $5.70 ($14,527)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 15 · 300 filings